{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:31:52Z","timestamp":1788481912727,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"PQ Bypass"},{"name":"PQ Bypass"},{"name":"PQ Bypass"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvascsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jvs.2020.02.043","type":"journal-article","created":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T23:57:18Z","timestamp":1586303838000},"page":"1648-1658.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["One-year results from the DETOUR I trial of the PQ Bypass DETOUR System for percutaneous femoropopliteal bypass"],"prefix":"10.1016","volume":"72","author":[{"given":"Dainis K.","family":"Krievins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Halena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dierk","family":"Scheinert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janis","family":"Savlovskis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Szopi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albrecht","family":"Kr\u00e4mer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Ouriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasthuri","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Holden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrej","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2020.02.043_bib1","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1161\/CIRCULATIONAHA.116.022546","article-title":"Percutaneous therapies for peripheral artery disease","volume":"134","author":"Shishehbor","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2020.02.043_bib2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/1358863X07079823","article-title":"Current state of endovascular treatment of femoro-popliteal artery disease","volume":"12","author":"Zeller","year":"2007","journal-title":"Vasc Med"},{"key":"10.1016\/j.jvs.2020.02.043_bib3","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2020.02.043_bib4","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/1358863X15597877","article-title":"An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: a supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)","volume":"20","author":"Jaff","year":"2015","journal-title":"Vasc Med"},{"key":"10.1016\/j.jvs.2020.02.043_bib5","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/S0140-6736(05)67704-5","article-title":"Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial","volume":"366","author":"Adam","year":"2005","journal-title":"Lancet"},{"issue":"Suppl","key":"10.1016\/j.jvs.2020.02.043_bib6","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1016\/j.jvs.2010.01.073","article-title":"Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy","volume":"51","author":"Bradbury","year":"2010","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2020.02.043_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3400\/avd.ra.18-00001","article-title":"When are endovascular and open bypass treatments preferred for femoropopliteal occlusive disease?","volume":"11","author":"AbuRahma","year":"2018","journal-title":"Ann Vasc Dis"},{"key":"10.1016\/j.jvs.2020.02.043_bib8","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/CIRCULATIONAHA.117.033502","article-title":"2017 Cardiovascular and stroke endpoint definitions for clinical trials","volume":"137","author":"Hicks","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2020.02.043_bib9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jvs.2006.08.074","article-title":"Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease","volume":"45","author":"Kedora","year":"2007","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2020.02.043_bib10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1148\/radiology.217.1.r00se0595","article-title":"Peripheral arterial obstruction: prospective study of treatment with a transluminally placed self-expanding stent-graft. International Trial Study Group","volume":"217","author":"Lammer","year":"2000","journal-title":"Radiology"},{"key":"10.1016\/j.jvs.2020.02.043_bib11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/152660280100800312","article-title":"Endovascular stent-grafting in the treatment of superficial femoral artery occlusive disease","volume":"8","author":"Bauermeister","year":"2001","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2020.02.043_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.RVI.0000052290.26939.cb","article-title":"Hemobahn stent-grafts for treatment of femoropopliteal arterial obstructions: midterm results of a prospective trial","volume":"14","author":"Jahnke","year":"2003","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvs.2020.02.043_bib13","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1583\/04-1327MR.1","article-title":"PTFE-covered self-expanding nitinol stents for the treatment of severe iliac and femoral artery stenoses and occlusions: final results from a prospective study","volume":"12","author":"Wiesinger","year":"2005","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2020.02.043_bib14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1148\/radiol.2232010971","article-title":"Femoropopliteal arteries: immediate and long-term results with a Dacron-covered stent-graft","volume":"223","author":"Ahmadi","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.jvs.2020.02.043_bib15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jvs.2010.05.018","article-title":"The history of the in situ saphenous vein bypass","volume":"53","author":"Connolly","year":"2011","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2020.02.043_bib16","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jvs.2011.01.034","article-title":"Predictors of surgical site infection after open lower extremity revascularization","volume":"54","author":"Greenblatt","year":"2011","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2020.02.043_bib17","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.jvs.2014.05.051","article-title":"Analysis of 30-day readmission after aortoiliac and infrainguinal revascularization using the American College of Surgeons National Surgical Quality Improvement Program data set","volume":"60","author":"Davenport","year":"2014","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2020.02.043_bib18","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.jvs.2013.12.032","article-title":"Risk factors for readmission after lower extremity bypass in the American College of Surgeons National Surgery Quality Improvement Program","volume":"59","author":"Zhang","year":"2014","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2020.02.043_bib19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12872-015-0025-1","article-title":"Outcomes of endovascular treatment for patients with TASC II D femoropopliteal occlusive disease: a single center study","volume":"15","author":"Guo","year":"2015","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jvs.2020.02.043_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2214\/ajr.138.1.119","article-title":"Long-segment arterial occlusion: percutaneous transluminal angioplasty","volume":"138","author":"Lu","year":"1982","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jvs.2020.02.043_bib21","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1177\/1526602816643834","article-title":"Covered vs uncovered stents for aortoiliac and femoropopliteal arterial disease: a systematic review and meta-analysis","volume":"23","author":"Hajibandeh","year":"2016","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2020.02.043_bib22","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1177\/1526602816650206","article-title":"Twelve-month results from the MAJESTIC trial of the Eluvia paclitaxel-eluting stent for treatment of obstructive femoropopliteal disease","volume":"23","author":"Muller-Hulsbeck","year":"2016","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2020.02.043_bib23","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jacc.2018.11.039","article-title":"Drug-eluting stent versus drug-coated balloon revascularization in patients with femoropopliteal arterial disease","volume":"73","author":"Bausback","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2020.02.043_bib24","first-page":"CD011319","article-title":"Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs","volume":"8","author":"Kayssi","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jvs.2020.02.043_bib25","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s00270-014-0904-3","article-title":"Calcium burden assessment and impact on drug-eluting balloons in peripheral arterial disease","volume":"37","author":"Fanelli","year":"2014","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvs.2020.02.043_bib26","doi-asserted-by":"crossref","first-page":"e011245","DOI":"10.1161\/JAHA.118.011245","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jvs.2020.02.043_bib27","first-page":"1250","article-title":"Patient-level meta-analysis of 999 claudicants undergoing primary femoropopliteal nitinol stent implantation","volume":"89","author":"Rocha-Singh","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"issue":"Suppl","key":"10.1016\/j.jvs.2020.02.043_bib28","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/j.jvs.2014.12.009","article-title":"Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication","volume":"61","author":"Conte","year":"2015","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2020.02.043_bib29","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ejvs.2017.07.018","article-title":"Editor's choice\u20142017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS)","volume":"55","author":"Aboyans","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2020.02.043_bib30","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.1016\/j.jvs.2016.03.142","article-title":"IP209. Perioperative complications increase risk of deep vein thrombosis in patients undergoing infrainguinal bypass","volume":"63","author":"D'Alessandro","year":"2016","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2020.02.043_bib31","doi-asserted-by":"crossref","first-page":"e005654","DOI":"10.1161\/CIRCINTERVENTIONS.117.005654","article-title":"Drug-coated balloon treatment for femoropopliteal artery disease. The IN.PACT global study long lesion imaging cohort","volume":"11","author":"Scheinert","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2020.02.043_bib32","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jvs.2014.10.008","article-title":"Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass","volume":"61","author":"Lumsden","year":"2015","journal-title":"J\u00a0Vasc Surg"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521420304705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521420304705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:28:56Z","timestamp":1760041736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521420304705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0741521420304705"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2020.02.043","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"One-year results from the DETOUR I trial of the PQ Bypass DETOUR System for percutaneous femoropopliteal bypass","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2020.02.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc. on behalf of the Society for Vascular Surgery.","name":"copyright","label":"Copyright"}]}}